"they have plenty of investors who want in" - The share price over the last 12+ months suggests the opposite
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025